Asahi Life Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Asahi Life Asset Management's BMY Position: Q1 2026 in Review
Asahi Life Asset Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 10,740 shares — an estimated $579K sold.
Asahi Life Asset Management first reported a position in BMY in Q4 2018 and held it in 21 quarters. The position peaked at $920K in Q4 2019. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Asahi Life Asset Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- Asahi Life Asset Management sold 10,740 Bristol-Myers Squibb shares in Q1 2026, an estimated $579K.
- Asahi Life Asset Management first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 21 quarters.
- Asahi Life Asset Management's Bristol-Myers Squibb position peaked at $920K in Q4 2019.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Asahi Life Asset Management's 13F filing for Q1 2026, filed 27 Apr 2026.